BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27

• Pharm Country

  Catalent Pharma Solutions & Redwood Bioscience Inc. Present SMARTag Technology At European Antibody Congress

  November 11, 2013

   · 

  3 min read
• Biotech Beach

  Amgen To Present At The Credit Suisse Annual Healthcare Conference

  November 11, 2013

   · 

  1 min read
• Deals

  Rare Disease Drug Developer Ultragenyx Pharmaceuticals Jumps Toward $86 Million IPO

  November 11, 2013

   · 

  1 min read
• Deals

  Novartis AG Sells Diagnostics Business Unit To Grifols For $1.68 Billion

  November 11, 2013

   · 

  9 min read
• Genetown

  Sensible Medical Innovations Raises $20 Million, Boston Scientific Corporation Leads Investment

  November 11, 2013

   · 

  1 min read
• Drug Development

  Tekmira Pharmaceuticals Corporation’s Partner Initiates Phase III Trial With LNP-Enabled Patisiran (ALN-TTR02)

  November 11, 2013

   · 

  1 min read
• Business

  Hemispherx Biopharma Announces Financial Results for the Three Months Ended September 30, 2013

  November 11, 2013

   · 

  1 min read
• PW Medtech Completes $180 Million Hong Kong IPO

  November 11, 2013

   · 

  1 min read
• Drug Development

  ERYtech Pharma Announces Positive DSMB Review Of Its Phase 2b Study In Acute Myeloid Leukemia

  November 11, 2013

   · 

  1 min read
• Lone Star Bio

  The Dow Chemical Company Release: DOW-COLORCON Controlled Release Alliance Launches METHOCEL™ DC2 To Help Reduce Development Time And Lower Manufacturing Costs At The 2013 American Association of Pharmaceutical Scientists Annual Meeting and Expo

  November 11, 2013

   · 

  1 min read